NEW YORK (GenomeWeb News) – Generation Health has contracted with PGXL Laboratories to be a preferred genetic testing lab providing molecular diagnostic test services for Generation Health.
In a pilot program starting next month, the partners will provide pharmacogenetic testing and diagnostic services to a limited number of patients through healthcare providers. In January 2011, those services will be opened up to all GH patients, Brad Esarey, director of sales and marketing for PGXL, said.
Terms of the agreement were not disclosed.
Based in Louisville, KY., PGXL is a molecular diagnostics lab. According to PGXL, it was the first laboratory in the country specifically CLIA certified to provide pharmacogenetic tests. Generation Health is a genetic benefit management company based in Upper Saddle River, NJ, partially owned by pharmacy services and benefit management firm CVS Caremark.